[1]王嘉萌,王博宇,丛慧芳.基于网络药理学探讨三仁汤治疗多囊卵巢综合征和2型糖尿病的“异病同治”作用机制[J].西部中医药,2025,38(03):48-58.[doi:10.12174/j.issn.2096-9600.2025.03.10]
　WANG Jiameng,WANG Boyu,CONG Huifang.Network Pharmacology-based Study on the Mchanism of Sanren Tang in the Treatment of PCOS and Type 2 Diabetes Mellitus[J].Western Journal of Traditional Chinese Medicine,2025,38(03):48-58.[doi:10.12174/j.issn.2096-9600.2025.03.10]
点击复制

基于网络药理学探讨三仁汤治疗多囊卵巢综合征和2型糖尿病的“异病同治”作用机制()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
38
期数:
2025年03期
页码:
48-58
栏目:
二次研究
出版日期:
2025-03-15

文章信息/Info

Title:
Network Pharmacology-based Study on the Mchanism of Sanren Tang in the Treatment of PCOS and Type 2 Diabetes Mellitus
作者:
王嘉萌1, 王博宇1, 丛慧芳2
1.黑龙江中医药大学，黑龙江 哈尔滨 150040
2.黑龙江中医药大学附属第二医院，黑龙江 哈尔滨 150001
Author(s):
WANG Jiameng1, WANG Boyu1, CONG Huifang2
1.Heilongjiang University of Chinese Medicine, Harbin 150040, China
2.The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150001, China
关键词:
多囊卵巢综合征; 2型糖尿病; 三仁汤; 异病同治
Keywords:
PCOS; type 2 diabetes mellitus; the same treatment for different diseases
分类号:
R259
DOI:
10.12174/j.issn.2096-9600.2025.03.10
文献标志码:
A
摘要:
目的应用网络药理学方法探讨三仁汤治疗多囊卵巢综合征（polycystic ovary syndrome，PCOS）和2型糖尿病（type 2 diabetes mellitus，T2DM）的作用机制，为中药“异病同治”提供科学的理论依据。 方法利用中药数据库（traditional Chinese medicine systems pharmacology database and analysis platform，TCMSP）、中医药综合数据库（traditional Chinese medicine integrated database，TCMID）、中医药整合药理学研究平台（integrative pharmacology-based research platform of traditional Chinese medicine，TCMIP）、中药成分靶点平台2.0（HIT 2.0）、传统中医分子机制生物信息学分析工具（bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine，BATMAN-TCM）、草药-中医证候-西医症状-成分-靶标-疾病关联网络数据库（symmap integrates traditional Chinese medicine，SymMap）等平台获取和筛选三仁汤的活性成分，并判断其生物活性；得到有效活性成分对应的靶点基因，输入Uniprot数据库，将靶点标准化；利用人类基因组数据库（the Human Gene database，GeneCards）、药物靶标数据库（therapeutic target database，TTD）、比较毒物基因组学数据库（the comparative toxicogenomics database，CTD）和药物银行数据库（DrugBank）获取PCOS和T2DM疾病靶点，得到三仁汤治疗PCOS和T2DM的共同作用靶点；采用Cytoscape 3.7.1软件绘制三仁汤“异病同治”的“单味药-活性成分-共同靶点”网络图；利用STRING平台绘制蛋白相互作用网络；通过注释、可视化和综合发现数据库（the database for annotation，visualization and integrated discovery，DAVID）、R语言（R studio）等平台进行生物过程分析，获得Mode节点分析、基因本体论（gene ontology，GO）富集分析和京都基因与基因组百科全书（kyoto encyclopedia of genes and genomes，KEGG）富集分析结果。 结果共筛选得到三仁汤有效活性成分50个、PCOS疾病靶点23 332个、T2DM疾病靶点28 438个，三仁汤“异病同治”PCOS和T2DM的共同靶点214个；蛋白质相互作用（protein-protein interaction networks，PPI）筛选出39个关键靶点；GO及KEGG富集分析结果显示：三仁汤“异病同治”主要涉及炎症反应、缺氧反应、凋亡过程、HIF-1信号通路、钙离子信号通路、胰岛素抵抗等；MCODE分析结果显示：三仁汤“异病同治”可能与活性氧反应、凋亡相关信号通路、白细胞介素17（interleukin-17，IL-17）信号通路、脂肪酸代谢过程等相关；三仁汤“异病同治”的关键靶点为蛋白激酶B1（protein kinase b alpha，AKT1）、肿瘤蛋白53（tumor protein p53，TP53）、半胱天冬酶3（caspase 3，CASP3）、肿瘤坏死因子（Tumor Necrosis Factor，TNF）及IL-6等。 结论三仁汤可能通过多靶点、多通路、多途径的作用机制，对PCOS和T2DM患者发挥作用，取得异病同治的效果。
Abstract:
ObjectiveTo provide science-based theoretical reference for "the same treatment for different diseases" in TCM by discussing the mechanism of Sanren Tang in the treatment of PCOS and type 2 diabetes mellitus (T2DM) based on network pharmacology. MethodsThe platforms including TCMSP, TCMID, and TCMIP, HIT2.0, BATMAN-TCM, and SymMap, were applied to obtain and screen out the active ingredients of Sanren Tang, and to judge its biological activity; The target genes corresponding to the effective active components were obtained, entered into the Uniprot database to standardize the targets; GeneCards, TTD, CTD and DrugBank were utilized to obain the targets of PCOS and T2DM, and the common targets of the decoction in the treatment of PCOS and T2DM; Cytoscape 3.7.1 software was adopted to draw the network of "single herb-active ingredient-common targets" of "the same treatment for different diseases" in Sanren Tang; STRING was used to map protein interaction network; biological processes were conducted through DAVID, and R studio to perform Mode analysis, GO enrichment analysis and KEGG enrichment analysis. ResultsThe study has yielded 50 effective active ingredients of the decoction, 23 332 targets of PCOS, 28 438 targets of T2DM, and 214 targets of the treatment of PCOS and T2DM with Sanren Tang on the foundation of the same treatment for different diseases; 39 key targets were identified for PPI; the results of GO and KEGG enrichment analysis showed that "the same treatment for different diseases" of Sanren Tang mainly involved inflammatory reaction, hypoxia reaction, apoptosis, HIF-1 signaling pathway, calcium ion channel and insulin resistance (IR); the results of MCODE analysis displayed that "the same treatment for different diseases" of Sanren Tang might be related to reactive oxygen species (ROS) response, apoptosis-related signaling pathway, IL-17 signaling pathway and fatty acid metabolism processes; the key targets of "the same treatment for different diseases" of Sanren Tang contained AKT1, TP53, CASP3, TNF and IL-6. Conclusion Sanren Tang could develop the effects in the treatment of PCOS and T2DM possibly through the mechanism of multi-target, multi-pathway and multi-way, so as to achieve the effects of treating different diseases with the same therapy.

相似文献/References:

[1]潘文,王贵霞,王晓萍.多囊卵巢综合征伴胰岛素抵抗的发病机制研究及中药干预作用[J].西部中医药,2012,25(12):121.
　PAN Wen,WANG Gui-xia,WANG Xiao-ping.Study on Pathogenesis of Polycystic Ovary Syndrome Complicated with Insulin Resistance and Intervention with Traditional Chinese Medicine[J].Western Journal of Traditional Chinese Medicine,2012,25(03):121.
[2]王针织,周丽虹,俞超芹△,等.补肾活血祛痰方治疗肥胖型与非肥胖型多囊卵巢综合征的疗效研究*[J].西部中医药,2014,27(04):1.
　WANG Zhenzhi,ZHOU Lihong,YU Chaoqin,et al.Study on Clinical Effects of Kidney-invigorating Blood-activating Phlegm-eliminating Prescription in Treating Polycystic Ovary Syndrome of Obesity Type and Non-obesity Type[J].Western Journal of Traditional Chinese Medicine,2014,27(03):1.
[3]苏庆华,张建伟△.多囊卵巢综合征中医证型与内分泌代谢指标相关性研究[J].西部中医药,2014,27(04):143.
　SU Qinghua,ZHANG Jianwei.Research on the Relativity between the Indexes of Metabolic Endocrinology and TCM Patterns of PCOS[J].Western Journal of Traditional Chinese Medicine,2014,27(03):143.
[4]康开彪,牛崇信,指导：潘文.潘文教授对多囊卵巢综合征中医病因的认识[J].西部中医药,2014,27(08):22.
[5]祁瑞芳.同型半胱氨酸、超敏 C- 反应蛋白在 2 型糖尿病合并脑梗死预测中的作用[J].西部中医药,2014,27(08):152.
[6]邱勇玉,李应东,赵信科,等.高血压病中医证型与 2 型糖尿病及其相关危险因素分析[J].西部中医药,2014,27(09):75.
[7]李东峰,指导：王志刚.王志刚主任医师治疗2型糖尿病“三级”防治思想辨治心得[J].西部中医药,2015,28(01):29.
[8]周雨聪,指导：刘召.红灵五黄汤治疗2型糖尿病90例[J].西部中医药,2015,28(04):99.
[9]杨国军.黄芪注射液对2型糖尿病患者血管功能及微循环状态的影响[J].西部中医药,2015,28(05):109.
[10]康学东,张瀚文.病证结合探讨2型糖尿病胰岛素抵抗[J].西部中医药,2015,28(11):112.

备注/Memo

备注/Memo:
王嘉萌（1997—），女，在读博士研究生。研究方向：中医药防治月经病。
更新日期/Last Update: 2025-03-15